The first study to report mutations in VAV1 was based on the genomic analysis of non-small cell lung cancer (NSCLC) that included lung adenocarcinoma (660 samples) and lung squamous cell carcinoma samples (484) [88,89]. Here, VAV1 is linked to non-small cell lung carcinoma.